Date | Title | Description | Source |
14.03.2024 | Cognition Therapeutics Announces Closing of $11.5 Million Pu... | - | globenewsw... |
13.03.2024 | Cognition Therapeutics Announces Public Offering | Cognition Therapeutics, a company focused on treating neurodegenerative disorders, has priced a publ... | parsers.vc... |
12.03.2024 | Cognition Therapeutics Announces Pricing of $11.5 Million Pu... | PURCHASE, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (“Cognition,” the “C... | einpresswi... |
11.03.2024 | Cognition Therapeutics Announces Proposed Public Offering of... | PURCHASE, N. Y., March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (“Cognition,” the “... | einpresswi... |
11.03.2024 | Cognition Therapeutics Announces Proposed Public Offering of... | - | globenewsw... |
11.03.2024 | Cognition Therapeutics Announces Pricing of $11.5 Million Pu... | - | globenewsw... |
06.03.2024 | Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Corr... | - | globenewsw... |
27.10.2023 | Cognition Therapeutics and Collaborators at Yale and ACTC An... | NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX) announced th... | einpresswi... |
04.05.2023 | Cognition Therapeutics Reports First Quarter 2023 Financial ... | /EIN News/ -- Completed enrollment for Phase 2 SEQUEL trial in mild-to-moderate Alzheimer’s disease ... | einpresswi... |
09.08.2022 | Cognition Therapeutics Reports Second Quarter 2022 Financial... | Cognition Therapeutics reported on 2nd quarter financial results and business updates including opti... | sofiafund.... |
04.08.2022 | Cognition Therapeutics Presents New Proteomic Data on Effect... | Analytic results in a study of Cognition Therapeutic’s CT1812, a drug targeting mild-to-moderate Alz... | sofiafund.... |
30.03.2022 | Cognition Therapeutics Reports Year End 2021 Financial Resul... | Read full Press Release here. | sofiafund.... |
18.11.2021 | Cognition Therapeutics Reports Third Quarter Financial Resul... | PURCHASE, N.Y., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a cli... | marketscre... |
13.10.2021 | Sofia portfolio company Cognition Therapeutics goes public | Women-led biopharmaceutical company Cognition Therapeutics newly public stock started trading Oct. 8... | sofiafund.... |
12.10.2021 | IPO roundup: These 3 tech exits will yield big gains for Pit... | After Duolingo’s hugely successful initial public offering in July, Pittsburgh tech leaders shared p... | technical.... |
04.10.2021 | Cognition Therapeutics launched its $40M IPO for Alzheimer’s... | Yet another Pittsburgh company is set to go public. But this time, it’s a small life sciences firm.
... | technical.... |
20.10.2020 | Cognition Therapeutics Elucidates Genetic Mutation that Prot... | Mutation Validates Cognition Approach to Oligomer Displacement | sofiafund.... |
31.08.2020 | Cognition Therapeutics Announces First Patient Dosed in SEQU... | Pittsburgh, August 27, 2020 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neuros... | sofiafund.... |
09.06.2020 | Cognition Therapeutics Receives $75.8 Million NIA Grant | Sofia portfolio company Cognition Therapeutics awarded $75.8M in competitive grant process, to study... | sofiafund.... |
08.06.2020 | Cognition Therapeutics Receives $75.8 Million NIA Grant | - | dolbyventu... |
20.11.2019 | Cognition Therapeutics to Give Webcast Presentation at Annua... | Pittsburgh, PA, November 20, 2019 (GLOBE NEWSWIRE) – Cognition Therapeutics, Inc., a clinical stage ... | sofiafund.... |
01.08.2019 | CogRX Gains Patent Coverage in Japan and China | Portfolio company CogRX gains patent coverage in Japan and China for Elayta, Cognition’s lead drug f... | sofiafund.... |
16.07.2019 | Cognition Therapeutics Receives $3.3 Million NIA Grant to Co... | Investigating Quantitative EEG as Biomarker of Patient Response to Treatment in Future Efficacy Stud... | sofiafund.... |
06.06.2019 | Cognition Therapeutics Appoints Anthony O. Caggiano M.D., Ph... | Pittsburgh, PA, June 05, 2019 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., today announced that ... | sofiafund.... |
26.03.2019 | Cognition Therapeutics Elects Lisa Ricciardi to its Board of... | Pittsburgh, PA, March 26, 2019 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neu... | sofiafund.... |
21.02.2019 | Cognition Therapeutics Receives European Patent Covering its... | Pittsburgh, PA, February 21, 2019 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage ... | sofiafund.... |
19.02.2019 | Cognition Therapeutics Announces Publication of Complete Res... | Elayta Crossed Blood Brain Barrier and Reached CNS Levels Associated in Preclinical Studies with Cog... | sofiafund.... |
04.10.2018 | CogRX receives $16.6M Grant for Phase II Study of Alzheimer’... | Sofia Fund portfolio company CogRX has received a $16.6M Multi-Year Grant for Phase II studies of it... | sofiafund.... |
27.03.2018 | Sofia Fund Makes Third Investment in Cognition Therapeutics | Sofia Fund recently announced its third investment in Cognition Therapeutics, Inc. (CogRx), a Pittsb... | sofiafund.... |
13.01.2016 | Five of Biotech Showcase’s most interesting startups | Interestingly, none of these startups are located in the usual geographical suspects: Boston, San Fr... | medcitynew... |
09.09.2015 | Daily funding roundup - September 9, 2015 | Didi Kuaidi scored $1B; Chef bagged $40M; Primus Power raised $25M
The battle for supremacy among e-... | vator.tv/n... |
08.09.2015 | Cognition Therapeutics Completes $12M Series B Financing | Cognition Therapeutics Inc., a Pittsburgh, PA-based pharmaceutical company focused on discovering an... | finsmes.co... |
08.09.2015 | Cognition Therapeutics Completes Oversubscribed $12 Million ... | - | dolbyventu... |
11.10.2013 | Cognition Therapeutics Raises $138K in Funding | Cognition Therapeutics, Inc., a Pittsburgh, PA-based drug discovery company focused on neurodegenera... | finsmes.co... |
23.05.2013 | After a restructure and an axed Merck deal, Acumen gains $20... | They found that soluble oligomers they called amyloid beta-derived diffusible ligands, or ADDLs, wer... | medcitynew... |
30.04.2013 | Women to watch: MedCity News’s nominees for 40 women over 40... | “…where our wealth of knowledge and know-how can move innovation into overdrive. It is a time where ... | medcitynew... |
08.01.2013 | Biotech CEO advancing Alzheimer’s disease treatment sees tha... | “We are probably one of the only biotechs in existence that has discovered a very significant and po... | medcitynew... |
12.12.2011 | Alzheimer’s drug developer Cognition Therapeutics raises $1.... | The latest funding was sourced from 16 investors, according to the regulatory document.
Cognition’s ... | medcitynew... |
25.10.2011 | At Biotech 2011, companies identify financing options | Government funding. If you want government funding, get to know your local congressmen, one panelist... | medcitynew... |
20.01.2011 | Cognition Therapeutics Closes $2.5M Series A1 Financing | Cognition Therapeutics, Inc., a Pittsburgh, PA-based drug discovery company developing novel, small ... | finsmes.co... |
20.01.2011 | Alzheimer’s drugmaker Cognition Therapeutics raises $2.5M | “This financing increases our investor base and further expands our national network to support the ... | medcitynew... |
16.07.2009 | Alzheimer’s-blocking drug developer Cognition Therapeutics r... | Cognition moved to Pittsburgh about two years ago from California. The advancements developed by the... | medcitynew... |
17.06.2009 | Louisiana pharma startup TheraVasc moves, readies for clinic... | “In 18 months, I hope to have completed clinical data and [to be] moving on to Phase II tests,” Gior... | medcitynew... |
- | At Biotech 2011, companies identify financing options | The challenge of identifying and establishing financing for early and mid-stage companies is forcing... | medcitynew... |
- | Alzheimer’s-blocking drug developer Cognition Therapeutics r... | PITTSBURGH, Pennsylvania — Cognition Therapeutics has raised $1.2 million to further study of its te... | medcitynew... |
- | Women to watch: MedCity News’s nominees for 40 women over 40... | One of the first things I learned in my conversations with industry insiders after joining MedCity N... | medcitynew... |
- | Alzheimer’s drugmaker Cognition Therapeutics raises $2.5M | Neurodegenerative disorders drug developer Cognition Therapeutics has raised $2.5 million in a Serie... | medcitynew... |
- | Five of Biotech Showcase’s most interesting startups | Presenting at the J.P. Morgan Healthcare Conference may confer some level of credibility to a compan... | medcitynew... |
- | Louisiana pharma startup TheraVasc moves, readies for clinic... | CLEVELAND, Ohio — A pharmaceutical start-up focused on cardiovascular disease plans to move to Cleve... | medcitynew... |
- | Biotech CEO advancing Alzheimer’s disease treatment sees tha... | Several companies have suffered setbacks with drugs to treat Alzheimer’s disease, but one biotechnol... | medcitynew... |
- | Alzheimer’s drug developer Cognition Therapeutics raises $1.... | Neurodegenerative disorders drug developer Cognition Therapeutics has raised $1.8 million in equity,... | medcitynew... |
- | After a restructure and an axed Merck deal, Acumen gains $20... | It’s been 17 years in the making, but Acumen Pharmaceuticals hasn’t given up hope for its approach t... | medcitynew... |